Thyroid cancer Drug's side effect on body mass revealed
NCT ID NCT07543887
First seen Apr 26, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study measured body composition changes in 15 adults with thyroid cancer who were already taking selpercatinib. Researchers used DXA scans to track lean mass and a special room to measure 24-hour energy use. The goal was to understand how the drug affects the body, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospital of Pisa
Pisa, PI, 56124, Italy
Conditions
Explore the condition pages connected to this study.